Subscribe
Logo small
Search

The European Parliament will work on the petition of National Medicines Manufacturers

MedExpress Team

Medexpress

Published July 15, 2022 07:54

The European Parliament will work on the petition of National Medicines Manufacturers - Header image
July 14 this year During the meeting of the Committee on Petitions of the European Parliament in Brussels, Grzegorz Rychwalski, vice-president of Polish Medicines Manufacturers, emphasized that Europeans are not safe today, because 80% of the substances used in the production of drugs used in the EU are imported from Asia.

The SARS-CoV-2 pandemic has shown that due to downtime in factories and disruptions in global transport, and due to increased demand for pharmaceuticals around the world, there may be a shortage of pharmaceuticals. Meanwhile, long-term shortages of life-saving drugs can cause greater losses among the population than many armed conflicts.
G. Rychwalski pointed out that the production of substances for the production of drugs in Europe will always be more expensive than in Asia, and drugs made of these substances will cost more. - This price difference is at the cost of drug safety, i.e. the guarantee of drug supplies even in crisis situations, which we have to bear. Hence the need for EU bodies to develop mechanisms to support the production capacity of pharmaceutical substances, he appealed.
He point...

Content locked

To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].

If you already have an account, please log in

Szukaj nowych pracowników

Dodaj ogłoszenie już za 4 zł dziennie*.

* 4 zł netto dziennie. Minimalny okres ekspozycji ogłoszenia to 30 dni.

Read also